INFLUENCE OF SILICA GEL, CONTAINING NANOPARTICLES OF GOLD AND SILVER, ON THE BIOCHEMICAL INDICES OF THE EXPERIMENTAL INFLAMMATION OF ORAL MUCOSA

Similar documents
INFLUENCE OF SILICAGEL CONTAINING GOLD AND SILVER NANOPARTICLES ON THE BIOCHEMICAL INDICES OF EXPERIMENTALLY-INDUCED INFLAMMATION OF ORAL MUCOSA

/ : Ternopil State Medical University named after I. Gorbachevskogo Voli sqare, 1, Ternopil, 46001, Ukraine

Keywords: coronary heart disease, oral hygiene, oral inflammatory diseases.

Investigation of the Role of Helicobacter Pylori ın the Etiopathogenesis of Current Aphthous Stomatitis

Impact of Photodynamic Therapy Applied by FotoSan on Periodontal Tissues Clinical Parameters

Organised By A B Shetty Memorial Institute of Dental Sciences in Association with ISP Study Group, Mangalore

THE MECHANISMS OF PERIODONTAL PATHOLOGY IN YOUNG ADULTS

Applications in Dermatology, Dentistry and LASIK Eye Surgery using LASERs

Index. Note: Page numbers of article titles are in boldface type.

Sergiy Guranych, Iryna Sokyrko, Tetyana Guranych*, Vasyl Stetsevyat

Endodontic Microbiology

The reprocessing of medical devices in Dentistry. Are there any differences to the reprocessing of surgical instruments?

Microbiota Transplantation Workshop: Oral Cavity

Mechanical Non Surgical Therapy: An Indispensable Tool

Oral Health & HIV. Professor Sudeshni Naidoo Department of Community Dentistry University of the Western Cape

Persson GR, Salvi GE, Heitz-Mayfield LJA et al. Antimicrobial therapy using a local drug delivery system (Arestin) in the treatment of

Show biofilm the red card

ROLE OF ORAL HYGIENE IN THE IMMUNO-GENETIC COMPONENT OF THE PATHOGENESIS OF ORAL LICHEN PLANUS

Effect of a Complex Preparation on Regeneration of the Experimental Soft Tissue Wound

ORAL HEALTH COMPLICATIONS?

Volume 2 Issue

Dental Care and Health An Update. Dr. Ranjini Pillai, DDS, MPH, FAGD, FICOI

PHOTOBIOSTIMULATION with INFRARED LED LIGHT (LIGHT MODULATION TECHNOLOGY) as an ADJUNCTIVE THERAPY in Maintenance Recall : A PRELIMINARY STUDY

The effect of probiotics on animal health: a focus on host s natural intestinal defenses

Doctor of Medical Sciences, Associate professor of the department of orthopedic stomatology

Microbiota and Oral Disease Prof. Dennis Cvitkovitch

VITAMINS, MINERALS AND THE GUT

Metabolite made from dried PectinGOLD JP-2 apple mass

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Helicobacter pylori:an Emerging Pathogen

Fukuoka Dental College, Fukuoka, Japan 2) Section of Periodontology, Department of Oral Rehabilitation,

oral health care and treatment of dental disorders in pregnancy

ARTICLE; MEDICAL BIOTECHNOLOGY Clinical assessment of the therapeutic effect of low-level laser therapy on chronic recurrent aphthous stomatitis

Dietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and

Faecalibacterium prausnitzii

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

DISEASES OF THE JAWS I

Effect of Systemically Administered Azithromycin in Early Onset Aggressive Periodontitis

Questions for final state exam

Microbial Complexes Detected in the Second/Third Molar Region in Patients With Asymptomatic Third Molars

Normal Flora. CLS 212: Medical Microbiology

Surgical Therapy. Tuesday, April 2, 13. Alessan"o Geminiani, DDS, MS

Oral Ulceration (Ulcers of the Mouth) Basics

Effect of tear deficiency on the course of endotoxin-induced keratitis

Overview of Periodontics for the General Practicioner

Ammara ismail, Fatima Javed, Memoona Ismail

Dysbiosis & Inflammation

Introduction to Dentistry

Assessment of effectiveness of complex treatment of apical and marginal periodontitis with thiotriazoline and chloramphenicol ointment

Effect of Tobacco Smoking on Oral Microbial Flora and the Relationship with Oral Health in Calabar, Nigeria

Specific Egg Yolk Antibody (Ovalgen PG) as a Novel Supportive Immunotherapy for Periodontitis

NEWSLETTER ABOUT LIGHT ACTIVATED DISINFECTION MARCH FotoSanNewsletter

Vitamins Minerals Chapter 12

HOW THE MICROBIOME AFFECTS OUR HEALTH

A STUDY OF PERIODONTAL DISEASE IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES SUMARRY

ARESTIN (minocycline hcl) subgingival powder

Periodontal (Gum) Disease

The use of antimicrobial

Delta Dental of Virginia Clinical Policy # 402

Downloaded from


A CASE REPORT OF: PSEUDOMEMBRANOUS CANDIDIASIS INDUCED BY LONG TERM SYSTEMIC CORTICOSTEROIDS THERAPY

The Experimental Gingivitis Model: key elements for conduction and design workshop

This article evaluates risks for inflammatory complications of dental implants. According to some authors the

actinomycetemcornitans and

Probiotics in the ICU. Who could benefit? Nadia J van Rensburg RD(SA) Groote Schuur Hospital, Cape Town

Pacific Protocols for the Dental Management of Patients with HIV Disease

Kartalin herbal cream NEW!

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

Chapter 4 Inflammation and Infection

A Contemporary Review of Current Philosophies for Managing Feline Oral Disease. Christopher J. Snyder DVM, DAVDC

When Teeth Go Bad How nurse advice can help reduce recurrences of dental disease. Callum Blair BVMS MRCVS

Antimicrobial Treatment for Advanced Periodontal Disease

WHY IS THIS IMPORTANT?

Microbes as Agents of Infectious Disease

Microbial and Genetic Testing in the Treatment of Periodontal Disease

SUPPORTING GUT HEALTH THROUGH CANCER TREATMENT. By Marina Silverio, RHN and Lorene Sauro, RHN

Oral Health Status of Pregnant Women

National Examining Board for Dental Nurses. NEBDN National Diploma in Dental Nursing

Imbalances in the Oral Microbiota associated with Oral Mucosal Diseases

Management of dental disease in the canine and feline patient

Please visit the C.E. Pavilion to validate your course attendance Or If There s a Line Go cdapresents.com

Strengthening the teeth and decreasing the effects of acid and bacteria on the teeth. Sodium Fluoride

UNIVERSITY OF NEVADA LAS VEGAS SCHOOL OF DENTAL MEDICINE

Svea Baumgarten, Dr. med. dent., M Sc, accredited implantologist as per the criteria of the DGZI (German Association of Dental Implantology) 1

The Effect of Ozone on the Lipid Peroxidation Processes in Case of Mandible Fractures.

Ozone-oxygen therapy in maxillo-facial bone surgery.

Surgical Procedure in Guided Tissue Regeneration with the. Inion GTR Biodegradable Membrane System

Microbes as Agents of Infectious Disease

Oral Health Applications for Probiotics

Best Practices in Oral Health for Older Adults -How to Keep My Bite in My Life!

Materials and Methods: Literature review and Authors opinion.

Resistant Starch for a Healthy Gut

Honey as nutrient and functional. Prof: Maha M. Saber Head of Complementary Medicine Department National Research Centre, Egypt

DURATION OF THE STUDY: JUNE-OCTOBER 2008 COST OF STUDY; 9400KSH SOURCE OF FUNDS: SELF INVESTIGATOR: GIKUNDA MARY KATHURE

Treatment of patients with parodontitis by antihomotoxic pharmacotherapy with Traumeel S

Case presentations: The pitfalls in diagnosis and management of oral lesions in cancer patients

Treatment of recurrent aphthous stomatitis major with metronidazole and ciprofloxacin

The role of gut microbiome in IBS

The effect of dietary Omega-3 polyunsaturated. fatty acids on experimental periodontitis lesions in. the mouse

Transcription:

Biomaterials INFLUENCE OF SILICA GEL, CONTAINING NANOPARTICLES OF GOLD AND SILVER, ON THE BIOCHEMICAL INDICES OF THE EXPERIMENTAL INFLAMMATION OF ORAL MUCOSA A.V. BORYSENKO 1, O. V. LYNOVYTSKA 2, O.B. TKACH 3, S. I. PALAMARCHUK 4 1 PhD in medical science, professor, Head of Operative Dentistry Department, O. O. Bogomolets National Medical University, Kyiv, Ukraine 2 PhD in philosophy, professor, Operative Dentistry Department, O. O. Bogomolets National Medical University, Kyiv, Ukraine 3 assistant, Operative Dentistry Department, O. O. Bogomolets National Medical University, Kyiv, Ukraine 4 PhD in philosophy, O. O. Bogomolets National Medical University, Kyiv, Ukraine Corresponding author: S. I. Palamarchuk; e-mail: serhiydentist@mail.ru Abstract Aim: to study the influence of drugs containing nanoparticles of gold and silver on the biochemical markers of inflammation and dysbiosis, under the experimental conditions on the inflammation model of the oral mucosa of rats. Materials and methods: the study was conducted on 42 white rats, in which the inflammation of the oral mucosa was experimentally induced by the use of Lipopolysaccharide (LPS). The preliminary application, on the oral mucosa, of the gel containing gold and silver nanoparticles was done 2 days before the experimentallyinduced inflammation. The activity of the biochemical indices of inflammation was determined in the homogenate of gingiva and cheek mucosa. Results and disscusion: Application of Lipopolysaccharide LPS on the rat oral mucosa caused the growth of elastase activity and MDA content, as a sign of inflammation. Application of gels containing Lyzomucoid with nanoparticles of gold and silver reduced the level of biochemical markers of inflammation, but only in the buccal mucosa. Catalase activity, decreased under the action of LPS, significantly increased in both gingiva and buccal mucosa. Conclusions: The gel containing Lyzomucoid preparations and nanoparticles of gold and silver significantly increases the activity of catalase and the antioxidant-prooxidant index (IPA) in both tissues. Decreased levels of oral mucosa dysbiosis were recorded. Keywords: oral cavity, lipopolysaccharide, nanoparticles, inflammation, anti oxidants, dysbiosis, gels, lyzomucoid. 1. INTRODUCTION Relevance of the study. Diseases of the oral mucosa are quite frequent (5-15 %) among other lesions of the oral cavity [1, 2]. Generally, they have an inflammatory nature and diverse clinical manifestations, from exudative inflammation to marked necrotic changes of the oral mucosa [3-5]. Lesions with significant loss of soft tissue of the oral mucosa are difficult to treat, often relapse of the disease appearing [6-8]. A large variety of drugs: antiseptics, enzymes, antibiotics, keratoplastic, etc. are used for the treatment of inflammatory lesions of the oral mucosa, yet data on their efficiency is rather contradictory. Antibacterial agents occupy an important place. The peculiarity of oral mucosa lesions treatment is that opportunistic microflora quickly gets used to antibiotics, which leads to significant changes in microbiota, expressed in the modification of the normal-to-pathogenic organisms ratio. This situation calls for further improvement of antibacterial drugs, namely the creation of more efficient means, to which microflora will get less accustomed. From this perspective, the use of drugs with gold and silver in the form of nanoparticles looks very promising. Nanoparticles have unique chemical and biological properties essential for therapeutic and preventive actions. Previous studies pf ours have shown the significant antibacterial effect of drugs on the basis of silver nanoparticles [9, 10], as well as their ability to enhance the antibiotic activity of Lyzomucoid, which contains lysozyme and the protease inhibitor ovomukoid [11, 12]. These drugs are adsorbed on fine silica, which greatly enhances their therapeutic effect [13]. Given this, one would assume the beneficial effects of these drugs and of the regeneration processes, including their anti-inflammatory effects and the effects on metabolic processes in the tissues of oral mucosa. International Journal of Medical Dentistry 163

A.V. BORYSENKO, O. V. LYNOVYTSKA, O.B. TKACH, S. I. PALAMARCHUK The aim of this study was to investigate the effect of drugs containing nanoparticles of gold and silver on the biochemical indices of inflammation and dysbiosis, under the experimental conditions on the inflammation model of the oral mucosa of rats. 2. MATERIALS AND METHODS The study was conducted on 42 white rats weighing 180 ± 10 g. Inflammation of the oral mucosa was caused by application of 0.5 ml of gel containing intestinal endotoxin - lipopolysaccharide (LPS ) [14, 15]. Pirogenal production Medgamal, Russia, lipopolysaccharide (LPS), derived from Salmonella typhi, was used as a drug. The gel was applied on the mucosa, at the rate of 75 mg/kg of body weight of animals for a period of 24 hours. 2 days before, a gel containing 0.5 g nanoparticles of gold (Au) or silver (Ag) was applied on the oral mucosa of the experimental rat. Silica gels containing nanoparticles of gold and silver were provided by the Department of Inorganic Chemistry, Taras Shevchenko National University of Kyiv. Gels for mucosa application were prepared by mixing l g of silica gel with nanoparticles of silver and gold, the drug Lyzomucoid (LM), and 95g of 3% sodium carboxymethylcellulose. The experimental animals were divided into 7 groups - 6 animals in each. In five groups of animals, application of gel containing nanoparticles of silver and gold was carried out in an amount of 0.5 ml per rat for 3 days, 2 days prior to applying the lipopolysaccharide gel (LPS) on the oral mucosa. Grou of animals, which received only the gel with LPS, served as the control 1. Group 3 of animals, which received gel Lyzomucoid and LPS, served as the control 2. The animals were taken out of the experiment on the 4th day (3 days of mucosa gels and 1 day of lipopolysaccharide (LPS) application, under thiopental anesthesia (20 mg / kg) by total bleeding. The mucosa of the gingiva and cheeks was cut and, in its homogenate, the biochemical activity of the inflammation indices - elastase activity [16], content of malondialdehyde [16], activity of antioxidant enzyme catalase was determined [16]. The ratio of catalase activity to the content of malondialdehyde (MDA) prooxidant - antioxidant index was calculated [16]. Also calculated in the mucosal homogenate of gingiva and cheeks were urease activity [17] and the level of lysozyme [11], determined by the ratio of oral dysbiosis - according to A.P. Levitskiy [18]. 3. RESULTS AND DISCUSSION Following the introduction of lipopolysaccharide (LPS), inflammation of oral (gingiva are cheek) mucosa was observed in the experimental animals, which caused a corresponding change in the biochemical parameters of inflammation (Table 1). The levels of malondialdehyde and elastase increased mainly in the gingival mucosa,. Previous application of the gel containing gold and silver nanoparticles had no significant effect on the elevated levels of elastase in the gingiva, which remains high, at the level of controls inflammation. Possibly, this is due to the very short duration (only 3 days) of application and to inadequate drug concentrations. The occurrence of inflammation interferes with lipid peroxidation, which leads to increased levels of malondialdehyde in the gingiva. Previous application of gel with nanoparticles of gold and silver results in a decrease in malondialdehyde. At a silver concentration of 400 mg/g, the levels of malondialdehyde decreased up to almost normal ranges: up to 13.8 ± 1.0 mmole/kg, with normal levels of 13.4 ± 0.8 mg/kg. 164 volume 20 issue 3 July / September 2016 pp. 163-170

INFLUENCE OF SILICA GEL, CONTAINING NANOPARTICLES OF GOLD AND SILVER, ON THE BIOCHEMICAL INDICES OF THE EXPERIMENTAL INFLAMMATION OF ORAL MUCOSA Table 1. Influence of silica gel, containing nanoparticles of gold and silver, on the biochemical indices of the experimental inflammation of rat gingiva Groups Elastase, μkat/kg MDA, mmole/kg 1. Normal 41 ±6 13.4 ±0.8 2. LPS - control 1 62 ±2 3. LPS+Lyzomucoid (LM) - control 2 57 ±2 pi>0.05 20.7 ± 2.8 14.7 ±1.2 4. LPS±LM±Au (5 nm, 500 mkg/g) 5. LPS±LM±Au (5 mkm, 400 mkg/g) 6. LPS±LM±Ag (5 mkm, 400 mkg/g) 7. LPS±LM±Ag (10 mkm, 400 mkg/g) 57 ±2 pi>0.05 P2=l 60 ±3 pi>0.5 59 ±3 59 ±2 17.5 ±1.8 >0, 2 15.0 ±1.4 16.3 ± 1.4 pi>0.05 13.8 ±1.0 p>0.5 grou, p2 - index of reliability of the difference from group 3. The inflammatory markers: malondialdehyde and elastase were increased in the mucosa of the cheek after introduction of lipopolysaccharide (LPS). Preliminary application of gel Lyzomucoid (LM) reduces to some extent the level of these biochemical parameters (Table 2). Application of gels with nanoparticles significantly enhance the anti-inflammatory effect of Lyzomucoid, but in neither group the level of inflammatory markers is below the normal range. International Journal of Medical Dentistry 165

A.V. BORYSENKO, O. V. LYNOVYTSKA, O.B. TKACH, S. I. PALAMARCHUK Table 2. Influence of silica gel, containing nanoparticles of gold and silver, on the biochemical indices of the experimental inflammation in rat cheek mucosa Groups Elastase, μkat/kg MDA, mmole/kg 1. Normal 51±3 13.1 ±1.2 2. LPS - control 1 69 ±2 21.3 ±1.9 3. LPS±Lyzomucoid (LM) - control 2 4. LPS±LM±Au (5 nm, 500 mkg/g) 5. LPS±LM±Au (5 mkm, 400 mkg/g) 6. LPS±LM±Ag (5 mkm, 400 mkg/g) 7. LPS±LM±Ag (10 mkm, 400 mkg/g) 66 ±11 pi 61 ±4 62 ±2 60 ±6 pi>0.05 57 ±6 19.7 ±1.6 pi 19.0 ±2.1 18.0 ±1.7 19.4 ±1.4 17.6 ±1.4 pi>0.05 grou, p2 - index of reliability of the difference from group 3. An index expressing the state of the antioxidant system is the level of catalase in the tissues of gingiva and oral mucosa. After lipopolysaccharide (LPS) application, the activity of catalase in the gingiva and cheek mucosa was significantly (p < 0.05) reduced, compared to normal values (Table 3). Application of the gel with lyzomucoid (LM) slightly increased the catalase activity, but this increase is statistically doubtful (p> 0.05). Application of gels with gold or silver nanoparticles enhances the activity of catalase in the tissues of gingiva and cheeks, however in neither group its level is below the normal level of activity. However, one can notice that the highest increase of activity occurred in the group of animals to which the gel with Lyzomucoid and nanoparticles of silver was applied. 166 volume 20 issue 3 July / September 2016 pp. 163-170

INFLUENCE OF SILICA GEL, CONTAINING NANOPARTICLES OF GOLD AND SILVER, ON THE BIOCHEMICAL INDICES OF THE EXPERIMENTAL INFLAMMATION OF ORAL MUCOSA Table 3. Influence of silica gel, containing nanoparticles of gold and silver, on the activity of catalase in the gingiva and cheek mucosa of rats under experimental inflammation Groups Gingiva Cheek 1. Normal 7.85 ± 0.42 6.97 ± 0.47 2. LPS - control 1 6.03 ± 0.22 5.22 ± 0.52 3. LPS+Lyzomucoid (LM) control 2 4. LPS+LM+Au (5 nm, 500 mkg/g) 5. LPS+LM+Au (5 mkm, 400 mkg/g) 6. LPS+LM+Ag (5 mkm, 400 mkg/g) 7. LPS+LM+Ag (10 mkm, 400 mkg/g) 6.14 + 0.87 pi>0.5 7.10 + 0.53 p>0.l 7.83 ± 0.40 p>0.8 <0, 01 7.84 + 0.71 p>0.9 <0, 01 8.58 + 0.14 <0, 01 6.00 ± 0.37 pi>0.05 6.45 ± 0.29 p>0.l 6.62 ± 0.33 >0, 2 6.96 ± 0.32 p>0.9 6.92 ± 0.44 p>0.8 grou, p2 - index of reliability of the difference from group 3. By calculating the ratio of catalase activity and the content of malondialdehyde (MDA), the prooxidant - antioxidant index (API), evidencing antioxidant and prooxidant balance of tissues, was determined. After application of lipopolysaccharide and inflammation in the mouth tissue, the antioxidant protection decreases, as evidenced by a sharp (almost 2-fold) reduction of the API index in cheek mucosa: up to 0.25 ± 0.1 versus 0.53 ± 0.14 under normal conditions. Application of the Lyzomucoid (LM) gel slightly increases the level of the antioxidant - prooxidant index (API) to 0.30 ±0.1. Application of gels with gold and silver nanoparticles increases even more the antioxidant system of the mucosa cheek tissue: under the influence of the gel containing silver nanoparticles measuring 10 microns (group number 7), API increased up to 0.39 + 0.1. Application of lipopolysaccharide on the oral mucosa of the mouth causes its inflammation, which leads to a significant (almost 3 times) increase in the activity of urease in gingiva (Table 4), causing a significant increase in the microbial contamination of gingival mucosa. Previous applications of the Lyzomucoid gel significantly reduced urease activity. Addition of silver and gold nanoparticles to the gel cause a more pronounced decrease in urease activity, International Journal of Medical Dentistry 167

A.V. BORYSENKO, O. V. LYNOVYTSKA, O.B. TKACH, S. I. PALAMARCHUK which is most pronounced in the case of silica containing gold nanoparticles with a size of 5 microns and concentration of 400 mg/d (group number 5). Table 4. Influence of silica gel, containing nanoparticles of gold and silver, on the activity of urease and lysozyme in the gingiva of rats under experimentally-induced inflammation Groups Urease, μkat/kg Lysozyme, units/kg 1. Normal 0.72 ±0.10 310±48 2. LPS - control 1 3. LPS±Lyzomucoid (LM) - control 2 4. LPS±LM±Au (5 nm, 500 mkg/g) 5. LPS±LM±Au (5 mkm, 400 mkg/g) 6. LPS±LM±Ag (5 mkm, 400 mkg/g) 2.35 ±0.13 p<0.001 1.54 ±0.08 p<0.001 1.45 ±0.10 p<0.001 pi<0.001 1.29 ±0.08 <0, 05 1.35 ±0.11 209 ± 20 227 ± 37 279 ±17 248 ± 28 233 ± 26 7. LPS±LM±Ag (10 mkm, 400 mkg/g) 1.38 ±0.09 248 ± 22 P2>0, 4 grou, p2 - index of reliability of the difference from group 3. After gingival disease (gingivitis) progress under the influence of lipopolysaccharide (LPS), the activity of lysozyme in gingival homogenate decreased (Table 4), indicating weakening of local nonspecific immunity [15]. Preliminary application of Lyzomucoid slightly increases the activity of lysozyme. Application of gels with nanoparticles of silver and gold significantly increases the activity of lysozyme, especially in the case of gel with 5 nm-sized gold nanoparticles and a concentration of 500 mg/d (group number 4). Table 5 shows the results of urease and lysozyme in cheek mucosa of rats. Progress of inflammation leads to a significant (spread over more than 3.5-fold) increase in urease activity in cheek mucosa. Application of Lyzomucoid leads to decreased activity of urease, yet without reaching the normal range. Application of gels with nanoparticles of silver and gold causes a significant decrease in urease activity. 168 volume 20 issue 3 July / September 2016 pp. 163-170

INFLUENCE OF SILICA GEL, CONTAINING NANOPARTICLES OF GOLD AND SILVER, ON THE BIOCHEMICAL INDICES OF THE EXPERIMENTAL INFLAMMATION OF ORAL MUCOSA Table 5. Influence of silica gel, containing nanoparticles of gold and silver, on the activity of urease and lysozyme in the oral mucosa of rats under experimentally-induced inflammation Groups Urease activity, μkat/kg Lysozyme activity, units/ kg 1. Normal 0.43 ±0.12 310 ±34 2. LPS - control 1 3. LPS±Lyzomucoid (LM) -control 2 4. LPS±LM±Au (5 nm, 500 mkg/g) 5. LPS±LM±Au (5 mkm, 400 mkg/g) 6. LPS±LM±Ag (5 mkm, 400 mkg/g) 7. LPS+LM+Ag (10 mkm, 400 mkg/g) 1.41 ±0.05 P< 0.001 1.21 ±0.05 p< 0.001 pi < 0..5 1.22 ±0.06 p< 0.001 pi < 0.05 >0, 9 1.35 ±0.12 p< 0.001 pi >0.3 >0, 2 1.09 ±0.12 pi < 0.05 >0.3 1.09 ±0.11 pi < 0.05 p2>0.3 196 ±20 217 ±31 p > 0.05 pi > 0.3 248 ± 22 p > 0.05 pi > 0.05 207 ±21 p < 0.05 pi > 0.4 206 ± 25 p < 0.05 pi > 0.4 206 ± 25 p < 0.05 pi > 0.4 p2>0.5 grou, p2 - index of reliability of the difference from group 3. 4.CONCLUSIONS Due to experimental inflammation of the oral mucosa in the mouth, the activity of lysozyme in the mucosa cheek of animals is significantly reduced. Application of the Lyzomucoid gel slightly increases the activity of lysozyme. Application of gels with nanoparticles of silver and gold causes a significant increase in the activity of lysozyme, which appears as most pronounced after the application of a gel with 5 nm-sized gold nanoparticles and a concentration of 500 mg/d (group number 4). Consequently, the use of gels with gold and silver nanoparticles has an antibiotic effect in the case of experimental inflammation of the mucosa of gingiva and cheeks. Experimental studies show that drugs with nanoparticles of gold and silver enhance the antiinflammatory effects of Lyzomucoid, this gain being possibly mediated through the inhibition of microorganisms in gingiva and cheek mucosa. The experimental data can serve as a basis for further development of drugs with nanoparticles of gold and silver for clinical use, in the treatment of periodontal diseases and oral mucosa. International Journal of Medical Dentistry 169

A.V. BORYSENKO, O. V. LYNOVYTSKA, O.B. TKACH, S. I. PALAMARCHUK References 1. Belikova IV. Prevalence of inflammatory diseases of the oral mucosa in the agricultural population and the major risk factors. Ukrainian Medical Almanac. 2003; 3:198-201. 2. Glazunov OA. Epidemiology of pathologic changes in oral mucosa of miners. Bulletin of dentistry. 2008;1:3-4. 3. Borowsky EV, Danilevsky NF. Atlas of diseases of the oral mucosa. Moscow:Medicine;1991, 320. 4. Danilevsky MV, Nesyn OF, Rakhniy ZI. Diseases of the oral mucosa. Kyiv:Zdorovia;1998. 408. 5. Danilevsky NF, Leontiev VK, Nesin AF, Rakhniy ZI. Diseases of the oral mucosa. Moscow : OJSC Dentistry;2001, 272 p. 6. Skiba VY. Principles of pathogenetic therapy of erosive and ulcerous lesions of oral mucosa. [PhD thesis]. Kyiv:Kyiv Medical University of UAFM; 1996. 7. Skiba VY. Application of drag "Vytalong" for treatment of chronic recurrent aphthous stomatitis. Dental technology. 2003;3-4 (12):70-2. 8. Pochtar VN, Macedon AB, Skiba VJ. Algorithm of local therapy of exudative erythema of oral mucosa. Part II. Clinical Dentistry. 2010; 2:34-36. 9. Borysenko AV, Tkach OB, Voloshchuk OM. Microbiological study of application of nanoparticles of gold and silver for the treatment of periodontitis. Scientific Visnyk of the National Medical Institute named after O.O.Bogomolets. 2012;1-2 (36-37):21-26 10. Borysenko AV, Tkach OB, Voloshchuk OM. Study of the influence of drags with gold nanoparticles on conditionally pathogenic microflora of root canal. Sovrem stomatologia. 2013; 1(65):11. 11. Levitskiy AP. Lysozyme instead of antibiotics. Odessa: KP OGT;2005, 74. 12. Levitskiy AP, Nykolyshyn AK, Stupak EP. Disbiotic aspects of pathogenesis, prevention and treatment of dental diseases. Problems of ecology and medicine. 2011;15(3-4): 103. 13. Kukurudz NI, Kutsik RV, Herelyuk VI, Kukurudz NI. Clinical and microbiological efficacy of the composition amizon -aethonium, immobilized on silica "Syllard -P" in the treatment of generalized periodontitis.liky. 2006;3-4:93-102. 14. Tamura M, Tokuda M, Nagaoka S, Takada H. Lypopolysaccharides of Bacteroides intermedias (Prerotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukine- 8 gene expression in human gingival fibroblast culture. Infect Immun. 1992;60(11):4932-7. 15. Levitskiy AP, Dem'yanenko SO, Makarenko OA. Inflammatory effect of LPS on the oral mucosa of rats. Odessa Med J. 2010; 2(118):9-11. 16. Levitskiy AP, Denga OV, Selivanskaya IA, Makarenko OA, Demyanenko SA, Tsiselskiy YV. The method of estimation of the degree of dysbiosis (dysbacteriosis) of organs and tissues. Patent of Ukraine 43140. IPC (2009) G01N 33/48. Application number u 200815092. Date of filling: 26.12.2008. Publ.: 10.08.2009. Bul. no.15. 17. Gavrikova LM, Segen IT. Urease activity of mouth fluid of patients with acute and odontogenic infection of maxillofacial area. Stomatologiia (Mosk). 1996;Spec No:49-50. 18. Levitskiy AP, Makarenko OA, Selivanskaya IA, Rossachanova LN, Denga OV, Pochtar VN, Skidan KV, Goncharuk SV. Enzymatic methods for determination of oral dysbiosis for screening pro-and prebiotics: method guidelines. GFC;2007. 170 volume 20 issue 3 July / September 2016 pp. 163-170